BACKGROUND: Decision support smartphone applications integrated with continuous glucose monitors may improve glycemic control in type 1 diabetes (T1D). We conducted a survey to understand trends and needs of potential users to inform the design of decision support technology. METHODS: A 70-question survey was distributed October 2017 through May 2018 to adults aged 18-80 with T1D from a specialty clinic and T1D Exchange online health community (myglu.org). The survey responses were used to evaluate potential features of a diabetes decision support tool by Likert scale and open responses. RESULTS: There were 1542 responses (mean age 46.1 years [SD 15.2], mean duration of diabetes 26.5 years [SD 15.8]). The majority (84.2%) have never used an app to manage diabetes; however, a large majority (77.8%) expressed interest in using a decision support app. The ability to predict and avoid hypoglycemia was the most important feature identified by a majority of the respondents, with 91% of respondents indicating the highest level of interest in these features. The task that respondents find most difficult was management of glucose during exercise (only 47% of participants were confident in glucose management during exercise). The respondents also highly desired features that help manage glucose during exercise (85% of respondents were interested). The responses identified integration and interoperability with peripheral devices/apps and customization of alerts as important. Responses from participants were generally consistent across stratified categories. CONCLUSIONS: These results provide valuable insight into patient needs in decision support applications for management of T1D.
BACKGROUND: Decision support smartphone applications integrated with continuous glucose monitors may improve glycemic control in type 1 diabetes (T1D). We conducted a survey to understand trends and needs of potential users to inform the design of decision support technology. METHODS: A 70-question survey was distributed October 2017 through May 2018 to adults aged 18-80 with T1D from a specialty clinic and T1D Exchange online health community (myglu.org). The survey responses were used to evaluate potential features of a diabetes decision support tool by Likert scale and open responses. RESULTS: There were 1542 responses (mean age 46.1 years [SD 15.2], mean duration of diabetes 26.5 years [SD 15.8]). The majority (84.2%) have never used an app to manage diabetes; however, a large majority (77.8%) expressed interest in using a decision support app. The ability to predict and avoid hypoglycemia was the most important feature identified by a majority of the respondents, with 91% of respondents indicating the highest level of interest in these features. The task that respondents find most difficult was management of glucose during exercise (only 47% of participants were confident in glucose management during exercise). The respondents also highly desired features that help manage glucose during exercise (85% of respondents were interested). The responses identified integration and interoperability with peripheral devices/apps and customization of alerts as important. Responses from participants were generally consistent across stratified categories. CONCLUSIONS: These results provide valuable insight into patient needs in decision support applications for management of T1D.
Authors: Rachel G Miller; Hemant D Mahajan; Tina Costacou; Akira Sekikawa; Stewart J Anderson; Trevor J Orchard Journal: Diabetes Care Date: 2016-09-21 Impact factor: 19.112
Authors: P G Jacobs; J El Youssef; R Reddy; N Resalat; D Branigan; J Condon; N Preiser; K Ramsey; M Jones; C Edwards; K Kuehl; J Leitschuh; U Rajhbeharrysingh; J R Castle Journal: Diabetes Obes Metab Date: 2016-08-15 Impact factor: 6.577
Authors: Stephanie Veazie; Kara Winchell; Jennifer Gilbert; Robin Paynter; Ilya Ivlev; Karen B Eden; Kerri Nussbaum; Nicole Weiskopf; Jeanne-Marie Guise; Mark Helfand Journal: J Gen Intern Med Date: 2018-05-08 Impact factor: 5.128
Authors: Shona J Livingstone; Daniel Levin; Helen C Looker; Robert S Lindsay; Sarah H Wild; Nicola Joss; Graham Leese; Peter Leslie; Rory J McCrimmon; Wendy Metcalfe; John A McKnight; Andrew D Morris; Donald W M Pearson; John R Petrie; Sam Philip; Naveed A Sattar; Jamie P Traynor; Helen M Colhoun Journal: JAMA Date: 2015-01-06 Impact factor: 56.272
Authors: Satish K Garg; Stuart A Weinzimer; William V Tamborlane; Bruce A Buckingham; Bruce W Bode; Timothy S Bailey; Ronald L Brazg; Jacob Ilany; Robert H Slover; Stacey M Anderson; Richard M Bergenstal; Benyamin Grosman; Anirban Roy; Toni L Cordero; John Shin; Scott W Lee; Francine R Kaufman Journal: Diabetes Technol Ther Date: 2017-01-30 Impact factor: 6.118
Authors: Jessica R Castle; Joseph El Youssef; Leah M Wilson; Ravi Reddy; Navid Resalat; Deborah Branigan; Katrina Ramsey; Joseph Leitschuh; Uma Rajhbeharrysingh; Brian Senf; Samuel M Sugerman; Virginia Gabo; Peter G Jacobs Journal: Diabetes Care Date: 2018-05-11 Impact factor: 19.112
Authors: Sarah M McGaugh; Stephanie Edwards; Howard Wolpert; Dessi P Zaharieva; Nany Gulati; Michael C Riddell Journal: J Diabetes Sci Technol Date: 2020-12-20